JPRN-UMIN000047083已完成未知
Antibody response to SARS-CoV-2 after the second and third doses of mRNA COVID-19 vaccine in Japanese hemodialysis patients - Effects after mRNA COVID-19 vaccine administration in hemodialysis patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 283
研究概览
简要总结
Significant SARS-CoV-2 antibody production is observed in hemodialysis patients after three doses of mRNA COVID-19 vaccine.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with no history of COVID-19
研究者
相似试验
尚未招募
不适用
SARS-CoV-2 Antibody responses in end-stage renal disease patients after COVID-19 VaccinatioESRDEnd-stage renal disease patients with renal replacement therapy receiving COVID-19 vaccineEnd stage kidney diseaseCOVID-19SARS-CoV-2VaccineRRTRenal replacement therapyTCTR20210510009Bamrasnaradura Infectious Diseases Institute70
Unknown
不适用
Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19COVIDTerminal Renal InsufficiencyNCT04367714Region MidtJylland Denmark300
已完成
不适用
Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.DialysisCovid19NCT04633915Saint Petersburg State University, Russia51
已完成
Unknown
Robust antibody response after the third mRNA coronavirus vaccination in Japanese hemodialysis patientsCOVID-19 in hemodialysis patientsJPRN-UMIN000049684Fujita Memorial Hospital, Internal Medicine294
已完成
4 期
SARS-CoV-2-specific immune responses after two versus three doses COVID-19 vaccination in end-stage renal disease patients and kidney transplant recipientsCOVID-19renal transplant, immunogenicity, safety, humoral immunity, cell-mediated immunityTCTR20210524002Faculty of Medicine Ramathibodi Hospital, Mahidol University120